These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 37823968)

  • 1. Intermittent fasting and Alzheimer's disease-Targeting ketone bodies as a potential strategy for brain energy rescue.
    Ye YC; Chai SF; Li XR; Wu MN; Cai HY; Wang ZJ
    Metab Brain Dis; 2024 Jan; 39(1):129-146. PubMed ID: 37823968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Ketone Bodies on Brain Metabolism and Function in Neurodegenerative Diseases.
    Jensen NJ; Wodschow HZ; Nilsson M; Rungby J
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain glucose and ketone utilization in brain aging and neurodegenerative diseases.
    Kapogiannis D; Avgerinos KI
    Int Rev Neurobiol; 2020; 154():79-110. PubMed ID: 32739015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketogenic Diet as a Promising Non-Drug Intervention for Alzheimer's Disease: Mechanisms and Clinical Implications.
    Xu Y; Zheng F; Zhong Q; Zhu Y
    J Alzheimers Dis; 2023; 92(4):1173-1198. PubMed ID: 37038820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ketone bodies in Alzheimer's disease in relation to neural hypometabolism, β-amyloid toxicity, and astrocyte function.
    Hertz L; Chen Y; Waagepetersen HS
    J Neurochem; 2015 Jul; 134(1):7-20. PubMed ID: 25832906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketogenic Diet: A Promising Neuroprotective Composition for Managing Alzheimer's Diseases and its Pathological Mechanisms.
    Sridharan B; Lee MJ
    Curr Mol Med; 2022; 22(7):640-656. PubMed ID: 34607541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketogenic diet improves motor performance but not cognition in two mouse models of Alzheimer's pathology.
    Brownlow ML; Benner L; D'Agostino D; Gordon MN; Morgan D
    PLoS One; 2013; 8(9):e75713. PubMed ID: 24069439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ketogenic diet as a potential treatment and prevention strategy for Alzheimer's disease.
    Broom GM; Shaw IC; Rucklidge JJ
    Nutrition; 2019 Apr; 60():118-121. PubMed ID: 30554068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary Neuroketotherapeutics for Alzheimer's Disease: An Evidence Update and the Potential Role for Diet Quality.
    Taylor MK; Swerdlow RH; Sullivan DK
    Nutrients; 2019 Aug; 11(8):. PubMed ID: 31443216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can ketones compensate for deteriorating brain glucose uptake during aging? Implications for the risk and treatment of Alzheimer's disease.
    Cunnane SC; Courchesne-Loyer A; St-Pierre V; Vandenberghe C; Pierotti T; Fortier M; Croteau E; Castellano CA
    Ann N Y Acad Sci; 2016 Mar; 1367(1):12-20. PubMed ID: 26766547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternate-day fasting improves cognitive and brain energy deficits by promoting ketone metabolism in the 3xTg mouse model of Alzheimer's disease.
    Ye Y; Fu C; Li Y; Sun J; Li X; Chai S; Li S; Hou M; Cai H; Wang Z; Wu M
    Exp Neurol; 2024 Nov; 381():114920. PubMed ID: 39142368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Beneficial effects of ketogenic diet for Alzheimer's disease management].
    Charlot A; Lernould A; Plus I; Zoll J
    Biol Aujourdhui; 2023; 217(3-4):253-263. PubMed ID: 38018953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's Disease and Type 2 Diabetes Mellitus: The Use of MCT Oil and a Ketogenic Diet.
    Takeishi J; Tatewaki Y; Nakase T; Takano Y; Tomita N; Yamamoto S; Mutoh T; Taki Y
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease.
    Croteau E; Castellano CA; Fortier M; Bocti C; Fulop T; Paquet N; Cunnane SC
    Exp Gerontol; 2018 Jul; 107():18-26. PubMed ID: 28709938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease.
    Klosinski LP; Yao J; Yin F; Fonteh AN; Harrington MG; Christensen TA; Trushina E; Brinton RD
    EBioMedicine; 2015 Dec; 2(12):1888-904. PubMed ID: 26844268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A unifying hypothesis of Alzheimer's disease. IV. Causation and sequence of events.
    Heininger K
    Rev Neurosci; 2000; 11 Spec No():213-328. PubMed ID: 11065271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketone bodies as a therapeutic for Alzheimer's disease.
    Henderson ST
    Neurotherapeutics; 2008 Jul; 5(3):470-80. PubMed ID: 18625458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketogenic Approaches for the Treatment of Alzheimer's Disease.
    Gabuzyan R; Lee C; Nygaard HB
    J Alzheimers Dis; 2024; 101(s1):S443-S453. PubMed ID: 39422952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers, ketone bodies, and the prevention of Alzheimer's disease.
    VanItallie TB
    Metabolism; 2015 Mar; 64(3 Suppl 1):S51-7. PubMed ID: 25468143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketones: potential to achieve brain energy rescue and sustain cognitive health during ageing.
    Myette-Côté É; Soto-Mota A; Cunnane SC
    Br J Nutr; 2022 Aug; 128(3):407-423. PubMed ID: 34581265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.